Rapid platelet inhibition after a single capsule of Aggrenox®: Challenging a conventional full-dose aspirin antiplatelet advantage?SEREBRUANY, Victor L; MALININ, Alex I; SANE, David C et al.American journal of hematology. 2003, Vol 72, Num 4, pp 280-281, issn 0361-8609, 2 p.Article

Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirinMALININ, Alex I; CALLAHAN, Kevin P; SEREBRUANY, Victor L et al.Thrombosis research. 2001, Vol 104, Num 4, pp 297-299, issn 0049-3848Article

Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery diseaseMALININ, Alex I; ATAR, Dan; CALLAHAN, Kevin P et al.European journal of pharmacology. 2003, Vol 462, Num 1-3, pp 139-143, issn 0014-2999, 5 p.Article

Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy)SEREBRUANY, Victor L; MALININ, Alex I; O'CONNOR, Christopher M et al.The American heart journal. 2003, Vol 146, Num 1, pp 91-98, issn 0002-8703, 8 p.Article

Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirinSANE, David C; MCKEE, Scott A; MALININ, Alex I et al.The American journal of cardiology. 2002, Vol 90, Num 8, pp 893-895, issn 0002-9149Article

Antiplatelet Profiles of the Fixed-Dose Combination of Extended-Release Dipyridamole and Low-Dose Aspirin Compared with Clopidogrel With or Without Aspirin in Patients with Type 2 Diabetes and a History of Transient Ischemic Attack : A Randomized, Single-Blind, 30-Day TrialSEREBRUANY, Victor L; MALININ, Alex I; POKOV, Alex N et al.Clinical therapeutics. 2008, Vol 30, Num 2, pp 249-259, issn 0149-2918, 11 p.Article

Uniform platelet activation exists before coronary stent implantation despite aspirin therapySEREBRUANY, Victor L; CUMMINGS, Charles C; MALININ, Alex I et al.The American heart journal. 2001, Vol 142, Num 4, pp 611-616, issn 0002-8703Article

Does heart failure etiology, New York Heart Association class, or ejection fraction affect the ability of clopidogrel to inhibit heightened platelet activity?MALININ, Alex I; OSHRINE, Benjamin R; SANE, David C et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 2, pp 91-96, issn 0957-5235, 6 p.Article

Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) Platelet substudySEREBRUANY, Victor L; MALININ, Alex I; CALLAHAN, Kevin P et al.The American heart journal. 2003, Vol 145, Num 4, pp 636-642, issn 0002-8703, 7 p.Article

Bleeding risks of combination vs. single antiplatelet therapy : a meta-analysis of 18 randomized trials comprising 129 314 patientsSEREBRUANY, Victor L; MALININ, Alex I; FERGUSON, James J et al.Fundamental & clinical pharmacology. 2008, Vol 22, Num 3, pp 315-321, issn 0767-3981, 7 p.Article

Variability in platelet responsiveness to clopidogrel among 544 individualsSEREBRUANY, Victor L; STEINHUBL, Steven R; BERGER, Peter B et al.Journal of the American College of Cardiology. 2005, Vol 45, Num 2, pp 246-251, issn 0735-1097, 6 p.Article

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: The Plavix Use for Treatment of Congestive Heart Failure (PLUTO-CHF) trialSEREBRUANY, Victor L; MALININ, Alex I; JEROME, Scott D et al.The American heart journal. 2003, Vol 146, Num 4, pp 713-720, issn 0002-8703, 8 p.Article

Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives : Valsartan Inhibits Platelets (VIP) trialSEREBRUANY, Victor L; POKOV, Alex N; MALININ, Alex I et al.The American heart journal. 2005, Vol 151, Num 1, pp 92-99, issn 0002-8703, 8 p.Article

Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapySEREBRUANY, Victor L; MALININ, Alex I; OSHRINE, Benjamin R et al.Thrombosis research. 2004, Vol 113, Num 3-4, pp 197-204, issn 0049-3848, 8 p.Article

Platelet activation in patients with congestive heart failure: Do we have enough evidence to consider clopidogrel?MALININ, Alex I; O'CONNOR, Christopher M; DZHANASHVILI, Alec I et al.The American heart journal. 2003, Vol 145, Num 3, pp 397-403, issn 0002-8703, 7 p.Article

Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trialsSEREBRUANY, Victor L; GLASSMAN, Alexander H; MALININ, Alex I et al.Blood coagulation & fibrinolysis. 2003, Vol 14, Num 6, pp 563-567, issn 0957-5235, 5 p.Article

Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formationGURBEL, Paul A; MALININ, Alex I; CALLAHAN, Kevin P et al.The American journal of cardiology. 2002, Vol 90, Num 3, pp 312-315, issn 0002-9149Article

Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarctionBAHR, Raymond D; GURBEL, Paul A; MALININ, Alex I et al.The American journal of cardiology. 2002, Vol 90, Num 3, pp 310-312, issn 0002-9149Article

Platelet function and fibrinolytic agents: two sides of a coin?CALLAHAN, Kevin P; MALININ, Alex I; GURBEL, Paul A et al.Cardiology. 2001, Vol 95, Num 2, pp 55-60, issn 0008-6312Article